Cargando…

Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults

Neurofilament light chain (NfL) has been associated with cognitive status in multiple neurodegenerative conditions. Studies about plasma NfL and cognitive decline in older adults are still limited. 504 older adults (median age 75 years) who expressed memory complaints were selected from the Multidom...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Lingxiao, Morley, John E., Aggarwal, Geetika, Nguyen, Andrew D., Vellas, Bruno, de Souto Barreto, Philipe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238930/ https://www.ncbi.nlm.nih.gov/pubmed/34183688 http://dx.doi.org/10.1038/s41598-021-91038-0

Ejemplares similares

Plasma Aβ and neurofilament light chain are associated with cognitive and physical function decline in non-dementia older adults
por: He, Lingxiao, et al.
Publicado: (2020)

Interactions Between Plasma Amyloid and Aging Markers to Determine Clinically Meaningful Cognitive Decline
por: Lu, Wan-Hsuan, et al.
Publicado: (2021)

Assessment of Plasma Amyloid-β(42/40) and Cognitive Decline Among Community-Dwelling Older Adults
por: Giudici, Kelly Virecoulon, et al.
Publicado: (2020)

Serum neurofilament light levels are predictive of all-cause mortality in late middle-aged individuals
por: Nguyen, Andrew D., et al.
Publicado: (2022)

White matter hyperintensity, neurofilament light chain, and cognitive decline
por: Dhana, Anisa, et al.
Publicado: (2022)

Plasma Neurofilament Light Chain and Clinical Diagnosis in Frontotemporal Dementia Syndromes
por: Ooi, Suyi, et al.
Publicado: (2022)

Examination of Neurofilament Light Chain Serum Concentrations, Physical Activity, and Cognitive Decline in Older Adults
por: Desai, Pankaja, et al.
Publicado: (2022)

Cross-sectional associations of plasma vitamin D with cerebral β-amyloid in older adults at risk of dementia
por: Nourhashemi, Fati, et al.
Publicado: (2018)

Periostin Plasma Levels and Changes on Physical and Cognitive Capacities in Community-Dwelling Older Adults
por: Sánchez-Sánchez, Juan Luis, et al.
Publicado: (2022)

Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
por: Giacomucci, Giulia, et al.
Publicado: (2022)

Cross-sectional Associations of Fatigue with Cerebral β-Amyloid in Older Adults at Risk of Dementia
por: Hooper, Claudie, et al.
Publicado: (2017)

Body Weight Variation Patterns as Predictors of Cognitive Decline over a 5 Year Follow-Up among Community-Dwelling Elderly (MAPT Study)
por: Giudici, Kelly Virecoulon, et al.
Publicado: (2019)

Plasma MCP-1 and changes on cognitive function in community-dwelling older adults
por: Sanchez-Sanchez, Juan Luis, et al.
Publicado: (2022)

Neurofilament light chain: a biomarker for genetic frontotemporal dementia
por: Meeter, Lieke H., et al.
Publicado: (2016)

Comparing Neurofilament Light Chain Levels in Serum and Plasma
por: Kwon, Hyuk Sung, et al.
Publicado: (2023)

Plasma inflammation‐related biomarkers are associated with intrinsic capacity in community‐dwelling older adults
por: Lu, Wan‐Hsuan, et al.
Publicado: (2023)

Physical activity and exercise in the context of SARS-Cov-2: A perspective from geroscience field
por: de Souto Barreto, Philipe, et al.
Publicado: (2021)

Elevated Levels of Serum Neurofilament Light Chain Associated with Cognitive Impairment in Vascular Dementia
por: Ma, Weibin, et al.
Publicado: (2020)

Plasma neurofilament light chain: A potential prognostic biomarker of dementia in adult Down syndrome patients
por: Shinomoto, Makiko, et al.
Publicado: (2019)

Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2021)

Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study
por: Truffi, Marta, et al.
Publicado: (2023)

Clinical value of cerebrospinal fluid neurofilament light chain in semantic dementia
por: Meeter, Lieke H H, et al.
Publicado: (2019)

Exploring Neurofilament Light Chain and Exosomes in the Genetic Forms of Frontotemporal Dementia
por: Zanardini, Roberta, et al.
Publicado: (2022)

Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021)

Predictors of decline in walking ability in community-dwelling Alzheimer’s disease patients: Results from the 4-years prospective REAL.FR study
por: Rolland, Yves, et al.
Publicado: (2013)

Plasma neurofilament light chain concentration in the inherited peripheral neuropathies
por: Sandelius, Åsa, et al.
Publicado: (2018)

Plasma neurofilament light chain concentration is increased in anorexia nervosa
por: Nilsson, Ida A. K., et al.
Publicado: (2019)

Linking Plasma Amyloid Beta and Neurofilament Light Chain to Intracortical Myelin Content in Cognitively Normal Older Adults
por: Fernandez-Alvarez, Marina, et al.
Publicado: (2022)

Association between urate-lowering therapies and cognitive decline in community-dwelling older adults
por: Molet-Benhamou, Luc, et al.
Publicado: (2022)

Associations of plasma phosphorylated tau181 and neurofilament light chain with brain amyloid burden and cognition in objectively defined subtle cognitive decline patients
por: Huang, Yanlu, et al.
Publicado: (2022)

Plasma Neurofilament Light and Future Declines in Cognition and Function in Alzheimer’s Disease in the FIT-AD Trial
por: Li, Danni, et al.
Publicado: (2021)

Correction: Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
por: Zhu, Nuole, et al.
Publicado: (2023)

Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia
por: Landqvist Waldö, Maria, et al.
Publicado: (2013)

Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease
por: Lin, Yung-Shuan, et al.
Publicado: (2018)

Plasma Neurofilament Light Chain Is Associated with Cognitive Impairment after Posterior Circulation Stroke
por: Jiang, Lianyan, et al.
Publicado: (2022)

Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson’s disease
por: Batzu, Lucia, et al.
Publicado: (2022)

Plasma tau and neurofilament light chain as biomarkers of Alzheimer's disease and their relation to cognitive functions
por: Abed, Sadiruldeen Sami, et al.
Publicado: (2023)

Plasma neurofilament light chain predicts progression in progressive supranuclear palsy
por: Rojas, Julio C., et al.
Publicado: (2016)

Neurofilament light chain level in plasma extracellular vesicles and Parkinson’s disease
por: Chung, Chen-Chih, et al.
Publicado: (2020)

A 1‐year randomized controlled trial of a nutritional blend to improve nutritional biomarkers and prevent cognitive decline among community‐dwelling older adults: The Nolan Study
por: Giudici, Kelly V., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_blb9aejcst40egoq3c67of9u3c